北美流动止血剂市场预测至 2028 年 - 区域分析 - 按材料、产品、应用和最终用户
市场调查报告书
商品编码
1494343

北美流动止血剂市场预测至 2028 年 - 区域分析 - 按材料、产品、应用和最终用户

North America Flowable Hemostats Market Forecast to 2028 - Regional Analysis - by Material, Product, Application, and End User

出版日期: | 出版商: The Insight Partners | 英文 122 Pages | 订单完成后即时交付

价格

北美可流动止血剂市场预计将从2022年的4.9474亿美元成长到2028年的7.4249亿美元。

导致产品创新的研发 (R&D) 活动推动北美可流动止血剂市场

医疗保健产业对止血剂产品的需求量很大。在过去的几年中,许多止血剂产品已被开发并在多种外科手术中使用。研究人员正在进行深入的研究和开发活动,从而实现产品创新。例如,2019年12月,Ethicon(强生医疗器材公司)的新产品「SURGIFLO止血基质」。 SURGIFLOW 可流动止血产品可在手术时止血,并且比 FLOSEAL(Baxter 製造)更快。此外,2018 年 1 月,领先的止血设备开发商和行销商 Z-Medica, LLC 推出了 QuikClot Control+,它可以帮助拯救生命并满足全国各地医院未满足的需求。 QuikClot Control+ 适用于暂时控制出现 III 级或 IV 级出血的患者的内臟器官间隙出血。它甚至可以用于控制严重流血的伤口,例如手术伤口和外伤。因此,预计导致产品创新的研发活动将在预测期内推动整个可流动止血剂市场的成长。

北美可流动止血剂市场概况

医疗保健产业对止血剂产品的需求量很大。在过去的几年中,许多止血剂产品已被开发并在多种外科手术中使用。研究人员正在进行深入的研究和开发活动,从而实现产品创新。例如,2019年12月,Ethicon(强生医疗器材公司)的新产品「SURGIFLO止血基质」。 SURGIFLOW 可流动止血产品可在手术时止血,并且比 FLOSEAL(Baxter 製造)更快。此外,2018 年 1 月,领先的止血设备开发商和行销商 Z-Medica, LLC 推出了 QuikClot Control+,它可以帮助拯救生命并满足全国各地医院未满足的需求。 QuikClot Control+ 适用于暂时控制出现 III 级或 IV 级出血的患者的内臟器官间隙出血。它甚至可以用于控制严重流血的伤口,例如手术伤口和外伤。因此,预计导致产品创新的研发活动将在预测期内推动整个可流动止血剂市场的成长。

北美流动止血剂市场收入及 2028 年预测(百万美元)

北美流动止血剂市场细分

北美流动止血剂市场分为材料、产品、应用、最终用户和国家。

根据材料,北美流动止血剂市场分为牛明胶和猪明胶。 2022 年,牛明胶细分市场在北美流动止血剂市场中占据更大份额。

就产品而言,北美可流动止血器市场分为组合止血器、被动止血器和主动式止血器。 2022 年,组合止血剂细分市场在北美可流动止血剂市场中占据最大份额。

根据应用,北美可流动止血剂市场分为一般外科、心臟外科、血管外科、骨科外科、神经和脊椎外科等。 2022 年,一般外科细分市场在北美流动止血剂市场中占最大份额。

根据最终用户,北美可流动止血剂市场分为医院和诊所、门诊手术中心等。 2022 年,医院和诊所在北美流动止血剂市场中占据最大份额。

依国家划分,北美流动止血剂市场分为美国、加拿大和墨西哥。 2022 年,美国将主导北美流动止血剂市场。

Baxter International Inc、Ethicon (Johnson & Johnson)、Pfizer Inc、Teleflex Incorporated、3-D Matrix Medical Technology、Biom'up 和 Aegis Lifesciences 是北美流动止血剂市场上的一些领先公司。

目录

第 1 章:简介

第 2 章:要点

第 3 章:研究方法

  • 覆盖范围
  • 二次研究
  • 初步研究

第 4 章:北美可流动止血剂市场 - 市场格局

  • 概述
  • 北美 PEST 分析
    • 北美 PEST 分析
  • 北美专家意见

第 5 章:北美可流动止血剂市场 - 主要市场动态

  • 市场驱动因素
    • 受伤和手术数量不断增加
    • 老年人口增加
  • 市场限制
    • 熟练专业人员短缺和报销政策不佳
  • 市场机会
    • 医院和手术中心数量不断增加
  • 未来的趋势
    • 导致产品创新的研发 (R&D) 活动
  • 影响分析

第 6 章:可流动止血剂市场 - 北美分析

  • 北美流动止血剂市场收入预测与分析

第 7 章:北美可流动止血剂市场收入预测与分析

  • 北美流动止血剂市场分析 - 按材料
  • 2021 年及 2028 年北美可流动止血剂市占率(按材料)(%)
  • 牛明胶
    • 概述
    • 牛明胶:北美流动止血剂市场 - 收入和 2028 年预测
  • 猪明胶
    • 概述
    • 猪明胶:北美流动止血剂市场 - 收入和 2028 年预测

第 8 章:北美可流动止血剂市场 - 按产品

  • 概述
  • 2021 年及 2028 年北美可流动止血剂市占率(按产品)
  • 组合止血钳
    • 概述
    • 组合止血器:北美可流动止血器市场 - 收入和 2028 年预测
  • 被动止血器
    • 概述
    • 被动止血器:北美可流动止血器市场 - 收入和 2028 年预测
  • 主动止血器
    • 概述
    • 主动止血器:北美可流动止血器市场 - 收入和 2028 年预测

第 9 章:北美可流动止血剂市场 - 按应用

  • 概述
  • 2021 年及 2028 年北美可流动止血剂市占率(按应用划分)(%)
  • 一般外科
    • 概述
    • 一般外科:北美可流动止血剂市场 - 收入和 2028 年预测
  • 心臟外科
    • 概述
    • 心臟手术:北美可流动止血剂市场 - 收入和 2028 年预测
  • 血管外科
    • 概述
    • 血管外科:北美可流动止血剂市场 - 收入和 2028 年预测
  • 骨科手术
    • 概述
    • 骨科手术:北美可流动止血剂市场 - 收入和 2028 年预测
  • 神经和脊椎外科
    • 概述
    • 神经和脊椎外科:北美可流动止血剂市场 - 收入和 2028 年预测
  • 其他的
    • 概述
    • 其他:北美可流动止血剂市场 - 收入和 2028 年预测

第 10 章:北美可流动止血器市场分析 - 按最终用户

  • 概述
  • 2021 年和 2028 年北美可流动止血剂市场份额(按最终用户划分)(%)
  • 医院和诊所
  • 门诊手术中心
  • 其他的

第 11 章:北美可流动止血剂市场收入和 2028 年预测 - 国家分析

  • 北美洲
    • 我们
    • 加拿大
    • 墨西哥

第 12 章:北美可流动止血剂市场-产业格局

  • 概述
  • 可流动止血剂市场的成长策略(%)
  • 有机发展
    • 概述
  • 无机发展
    • 概述

第 13 章:公司简介

  • Baxter International Inc
  • Ethicon (Johnson & Johnson)
  • Pfizer Inc.
  • Teleflex Incorporated
  • 3-D Matrix Medical Technology
  • Biom'up
  • Aegis Lifesciences

第 14 章:附录

Product Code: BMIRE00029826

The North America flowable hemostats market is expected to grow from US$ 494.74 million in 2022 to US$ 742.49 million by 2028. It is estimated to grow at a CAGR of 7.0% from 2022 to 2028.

Research and Development (R&D) Activities Leading to Product Innovations Fuel North America Flowable Hemostats Market

Hemostat products are high in demand in the healthcare industry. Over the past several years, many hemostat products have been developed and utilized in several surgical procedures. Researchers are carrying out intensive research and development activities resulting in product innovations. For Instance, In December 2019, Ethicon's (Johnson & Johnson Medical Device Companies) new product, "SURGIFLO Hemostatic Matrix." SURGIFLOW flowable hemostatic product stops bleeding while performing surgery and is faster than FLOSEAL (manufactured by Baxter). Furthermore, In January 2018, Z-Medica, LLC, a leading developer and marketer of hemostatic devices introduced QuikClot Control+ which can help save lives and fill the unmet need of hospitals across the country. QuikClot Control+ is indicated for temporary control of internal organ space bleeding for patients displaying class III or class IV bleeding. It may even be used to control severe bleeding wounds such as surgical wounds and traumatic injuries. Thus, research and development activities leading to product innovations are predicted to deliver an impetus for the growth of the overall flowable hemostats market during the forecast period.

North America Flowable Hemostats Market Overview

Hemostat products are high in demand in the healthcare industry. Over the past several years, many hemostat products have been developed and utilized in several surgical procedures. Researchers are carrying out intensive research and development activities resulting in product innovations. For Instance, In December 2019, Ethicon's (Johnson & Johnson Medical Device Companies) new product, "SURGIFLO Hemostatic Matrix." SURGIFLOW flowable hemostatic product stops bleeding while performing surgery and is faster than FLOSEAL (manufactured by Baxter). Furthermore, In January 2018, Z-Medica, LLC, a leading developer and marketer of hemostatic devices introduced QuikClot Control+ which can help save lives and fill the unmet need of hospitals across the country. QuikClot Control+ is indicated for temporary control of internal organ space bleeding for patients displaying class III or class IV bleeding. It may even be used to control severe bleeding wounds such as surgical wounds and traumatic injuries. Thus, research and development activities leading to product innovations are predicted to deliver an impetus for the growth of the overall flowable hemostats market during the forecast period.

North America Flowable Hemostats Market Revenue and Forecast to 2028 (US$ Million)

North America Flowable Hemostats Market Segmentation

The North America flowable hemostats market is segmented into material, product, application, end user, and country.

Based on material, the North America flowable hemostats market is bifurcated into bovine gelatin & porcine gelatin. The bovine gelatin segment held a larger share of the North America flowable hemostats market in 2022.

In terms of product, the North America flowable hemostats market is segmented into combination hemostats, passive hemostats, and active hemostats. The combination hemostats segment held the largest share of the North America flowable hemostats market in 2022.

Based on Application, the North America flowable hemostats market is categorized into general surgery, cardiac surgery, vascular surgery, orthopedic surgery, neuro and spine surgery, and others. The general surgery segment held the largest share of the North America flowable hemostats market in 2022.

Based on end user, the North America flowable hemostats market is segmented into hospitals and clinics, ambulatory surgery centers, and others. The hospitals and clinics segment held the largest share of the North America flowable hemostats market in 2022.

By country, the North America flowable hemostats market is categorized into the US, Canada, and Mexico. The US dominated the North America flowable hemostats market in 2022.

Baxter International Inc, Ethicon (Johnson & Johnson), Pfizer Inc, Teleflex Incorporated, 3-D Matrix Medical Technology, Biom'up, and Aegis Lifesciences are some of the leading companies operating in the North America North America flowable hemostats market.

Table Of Contents

1. Introduction

  • 1.1 Scope of the Study
  • 1.2 The Insight Partners Research Report Guidance
  • 1.3 Market Segmentation
    • 1.3.1 North America Flowable Hemostats Market - By Material
    • 1.3.2 North America Flowable Hemostats Market - By Product
    • 1.3.3 North America Flowable Hemostats Market - By Application
    • 1.3.4 North America Flowable Hemostats Market - By End User
    • 1.3.5 North America Flowable Hemostats Market - By Country

2. Key Takeaways

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. North America Flowable Hemostats Market - Market Landscape

  • 4.1 Overview
  • 4.2 North America PEST Analysis
    • 4.2.1 North America PEST Analysis
  • 4.3 North America Experts Opinion

5. North America Flowable Hemostats Market - Key Market Dynamics

  • 5.1 Market Drivers
    • 5.1.1 Increasing Number of Injuries and Surgical Procedures
    • 5.1.2 Rising Geriatric Population
  • 5.2 Market Restraints
    • 5.2.1 Shortage of Skilled Professionals and Poor Reimbursement Policies
  • 5.3 Market Opportunities
    • 5.3.1 Increasing Number of Hospitals and Surgical Centers
  • 5.4 Future Trends
    • 5.4.1 Research and Development (R&D) Activities Leading to Product Innovations
  • 5.5 Impact Analysis

6. Flowable Hemostats Market - North America Analysis

  • 6.1 North America Flowable Hemostats Market Revenue Forecast & Analysis

7. North America Flowable Hemostats Market Revenue Forecast & Analysis

  • 7.1 North America Flowable Hemostats Market Analysis - By Material
  • 7.2 North America Flowable Hemostats Market Share, by Material, 2021 and 2028 (%)
  • 7.3 Bovine Gelatin
    • 7.3.1 Overview
    • 7.3.2 Bovine Gelatin: North America Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
  • 7.4 Porcine Gelatin
    • 7.4.1 Overview
    • 7.4.2 Porcine Gelatin: North America Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)

8. North America Flowable Hemostats Market- By Product

  • 8.1 Overview
  • 8.2 North America Flowable Hemostats Market Share, by Product, 2021 and 2028 (%)
  • 8.3 Combination Hemostat
    • 8.3.1 Overview
    • 8.3.2 Combination Hemostat: North America Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
  • 8.4 Passive Hemostat
    • 8.4.1 Overview
    • 8.4.2 Passive Hemostat: North America Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
  • 8.5 Active Hemostat
    • 8.5.1 Overview
    • 8.5.2 Active Hemostat: North America Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)

9. North America Flowable Hemostats Market- By Application

  • 9.1 Overview
  • 9.2 North America Flowable Hemostats Market Share, by Application, 2021 and 2028 (%)
  • 9.3 General Surgery
    • 9.3.1 Overview
    • 9.3.2 General Surgery: North America Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
  • 9.4 Cardiac Surgery
    • 9.4.1 Overview
    • 9.4.2 Cardiac Surgery: North America Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
  • 9.5 Vascular Surgery
    • 9.5.1 Overview
    • 9.5.2 Vascular Surgery: North America Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
  • 9.6 Orthopedic Surgery
    • 9.6.1 Overview
    • 9.6.2 Orthopedic Surgery: North America Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
  • 9.7 Neuro and Spine Surgery
    • 9.7.1 Overview
    • 9.7.2 Neuro and Spine Surgery: North America Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
  • 9.8 Others
    • 9.8.1 Overview
    • 9.8.2 Others: North America Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)

10. North America Flowable Hemostats Market Analysis - By End User

  • 10.1 Overview
  • 10.2 North America Flowable Hemostats Market Share, by End User, 2021 and 2028, (%)
  • 10.3 Hospitals and Clinics
    • 10.3.1 Overview
    • 10.3.2 Hospitals and Clinics: North America Flowable Hemostats Market - Revenue and Forecast to 2028 (US$ Million)
  • 10.4 Ambulatory Surgery Centers
    • 10.4.1 Overview
    • 10.4.2 Ambulatory Surgery Centers: North America Flowable Hemostats Market - Revenue and Forecast to 2028 (US$ Million)
  • 10.5 Others
    • 10.5.1 Overview
    • 10.5.2 Others: North America Flowable Hemostats Market - Revenue and Forecast to 2028 (US$ Million)

11. North America Flowable Hemostats Market Revenue and Forecasts to 2028 - Country Analysis

  • 11.1 North America: Flowable Hemostats Market
    • 11.1.1 Overview
    • 11.1.2 North America: Flowable Hemostats Market, by Country, 2022 & 2028 (%)
      • 11.1.2.1 US: Flowable Hemostats Market - Revenue and Forecast to 2028 (US$ Million)
        • 11.1.2.1.1 Overview
      • 11.1.2.2 US: Flowable Hemostats Market - Revenue and Forecast to 2028 (USD Million)
        • 11.1.2.2.1 US: Flowable Hemostats Market, by Material- Revenue and Forecast to 2028 (USD Million)
        • 11.1.2.2.2 US: Flowable Hemostats Market, by Product- Revenue and Forecast to 2028 (USD Million)
        • 11.1.2.2.3 US: Flowable Hemostats Market, by Application- Revenue and Forecast to 2028 (USD Million)
        • 11.1.2.2.4 US: Flowable Hemostats Market, End User - Revenue and Forecast to 2028 (USD Million)
      • 11.1.2.3 Canada: Flowable Hemostats Market - Revenue and Forecast to 2028 (US$ Million)
        • 11.1.2.3.1 Overview
        • 11.1.2.3.2 Canada: Flowable Hemostats Market - Revenue and Forecast to 2028 (USD Million)
        • 11.1.2.3.3 Canada: Flowable Hemostats Market, by Material- Revenue and Forecast to 2028 (USD Million)
        • 11.1.2.3.4 Canada: Flowable Hemostats Market, by Product- Revenue and Forecast to 2028 (USD Million)
        • 11.1.2.3.5 Canada: Flowable Hemostats Market, by Application- Revenue and Forecast to 2028 (USD Million)
        • 11.1.2.3.6 Canada: Flowable Hemostats Market, End User - Revenue and Forecast to 2028 (USD Million)
      • 11.1.2.4 Mexico: Flowable Hemostats Market - Revenue and Forecast to 2028 (US$ Million)
        • 11.1.2.4.1 Overview
        • 11.1.2.4.2 Mexico: Flowable Hemostats Market - Revenue and Forecast to 2028 (USD Million)
        • 11.1.2.4.3 Mexico: Flowable Hemostats Market, by Material- Revenue and Forecast to 2028 (USD Million)
        • 11.1.2.4.4 Mexico: Flowable Hemostats Market, by Product- Revenue and Forecast to 2028 (USD Million)
        • 11.1.2.4.5 Mexico: Flowable Hemostats Market, by Application- Revenue and Forecast to 2028 (USD Million)
        • 11.1.2.4.6 Mexico: Flowable Hemostats Market, End User - Revenue and Forecast to 2028 (USD Million)

12. North America Flowable Hemostats Market-Industry Landscape

  • 12.1 Overview
  • 12.2 Growth Strategies in the Flowable Hemostats Market (%)
  • 12.3 Organic Developments
    • 12.3.1 Overview
  • 12.4 Inorganic Developments
    • 12.4.1 Overview

13. Company Profiles

  • 13.1 Baxter International Inc
    • 13.1.1 Key Facts
    • 13.1.2 Business Description
    • 13.1.3 Products and Services
    • 13.1.4 Financial Overview
    • 13.1.5 SWOT Analysis
    • 13.1.6 Key Developments
  • 13.2 Ethicon (Johnson & Johnson)
    • 13.2.1 Key Facts
    • 13.2.2 Business Description
    • 13.2.3 Products and Services
    • 13.2.4 Financial Overview
    • 13.2.5 SWOT Analysis
    • 13.2.6 Key Developments
  • 13.3 Pfizer Inc.
    • 13.3.1 Key Facts
    • 13.3.2 Business Description
    • 13.3.3 Products and Services
    • 13.3.4 Financial Overview
    • 13.3.5 SWOT Analysis
    • 13.3.6 Key Developments
  • 13.4 Teleflex Incorporated
    • 13.4.1 Key Facts
    • 13.4.2 Business Description
    • 13.4.3 Products and Services
    • 13.4.4 Financial Overview
    • 13.4.5 SWOT Analysis
    • 13.4.6 Key Developments
  • 13.5 3-D Matrix Medical Technology
    • 13.5.1 Key Facts
    • 13.5.2 Business Description
    • 13.5.3 Products and Services
    • 13.5.4 Financial Overview
    • 13.5.5 SWOT Analysis
    • 13.5.6 Key Developments
  • 13.6 Biom'up
    • 13.6.1 Key Facts
    • 13.6.2 Business Description
    • 13.6.3 Products and Services
    • 13.6.4 Financial Overview
    • 13.6.5 SWOT Analysis
    • 13.6.6 Key Developments
  • 13.7 Aegis Lifesciences
    • 13.7.1 Key Facts
    • 13.7.2 Business Description
    • 13.7.3 Products and Services
    • 13.7.4 Financial Overview
    • 13.7.5 SWOT Analysis
    • 13.7.6 Key Developments

14. Appendix

  • 14.1 About The Insight Partners
  • 14.2 North America Glossary of Terms

List Of Tables

  • Table 1. US: Flowable Hemostats Market, by Material - Revenue and Forecast to 2028 (USD Million)
  • Table 2. US: Flowable Hemostats Market, by Product- Revenue and Forecast to 2028 (USD Million)
  • Table 3. US: Flowable Hemostats Market, by Application- Revenue and Forecast to 2028 (USD Million)
  • Table 4. US: Flowable Hemostats Market, End User - Revenue and Forecast to 2028 (USD Million)
  • Table 5. Canada: Flowable Hemostats Market, by Material - Revenue and Forecast to 2028 (USD Million)
  • Table 6. Canada: Flowable Hemostats Market, by Product- Revenue and Forecast to 2028 (USD Million)
  • Table 7. Canada: Flowable Hemostats Market, by Application- Revenue and Forecast to 2028 (USD Million)
  • Table 8. Canada: Flowable Hemostats Market, End User - Revenue and Forecast to 2028 (USD Million)
  • Table 9. Mexico: Flowable Hemostats Market, by Material - Revenue and Forecast to 2028 (USD Million)
  • Table 10. Mexico: Flowable Hemostats Market, by Product- Revenue and Forecast to 2028 (USD Million)
  • Table 11. Mexico: Flowable Hemostats Market, by Application- Revenue and Forecast to 2028 (USD Million)
  • Table 12. Mexico: Flowable Hemostats Market, End User - Revenue and Forecast to 2028 (USD Million)
  • Table 13. Organic Developments in the Flowable Hemostats Market
  • Table 14. Inorganic Developments in the Flowable Hemostats Market
  • Table 15. North America Glossary of Terms

List Of Figures

  • Figure 1. North America Flowable Hemostats Market Segmentation
  • Figure 2. North America Flowable Hemostats Market, By Country
  • Figure 3. North America Flowable Hemostats Market Overview
  • Figure 4. Bovine Gelatin Holds Maximum Share in North America Flowable Hemostats Market
  • Figure 5. North America Flowable Hemostats Market, by Country (US$ Million)
  • Figure 6. North America Flowable Hemostats Market, Market Attractiveness
  • Figure 7. North America: PEST Analysis
  • Figure 8. North America Experts Opinion
  • Figure 9. Impact Analysis
  • Figure 10. North America Flowable Hemostats Market - Revenue Forecast and Analysis - 2020- 2028
  • Figure 11. North America Flowable Hemostats market Share, by Material, 2021 and 2028 (%)
  • Figure 12. Bovine Gelatin: North America Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
  • Figure 13. Porcine Gelatin: North America Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
  • Figure 14. North America Flowable Hemostats Market Share, by Product, 2021 and 2028 (%)
  • Figure 15. Combination Hemostat: North America Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
  • Figure 16. Passive Hemostat: North America Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
  • Figure 17. Active Hemostat: North America Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
  • Figure 18. North America Flowable Hemostats Market Share, by Application, 2021 and 2028 (%)
  • Figure 19. General Surgery: North America Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
  • Figure 20. Cardiac Surgery: North America Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
  • Figure 21. Vascular Surgery: North America Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
  • Figure 22. Orthopedic Surgery: North America Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
  • Figure 23. Neuro and Spine Surgery: North America Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
  • Figure 24. Others: North America Flowable Hemostats Market- Revenue and Forecast to 2028 (US$ Million)
  • Figure 25. North America Flowable Hemostats Gown Market Share, by End User, 2021 and 2028 (%)
  • Figure 26. Hospitals and Clinics: North America Flowable Hemostats Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 27. Ambulatory Surgery Centers: North America Flowable Hemostats Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 28. Others: North America Flowable Hemostats Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 29. North America Flowable Hemostats Market Revenue Overview, by Country, 2021 (US$ MN)
  • Figure 30. North America: Flowable Hemostats Market, by Country, 2022 & 2028 (%)
  • Figure 31. US: Flowable Hemostats Market Revenue and Forecast to 2028 (US$ Mn)
  • Figure 32. Canada: Flowable Hemostats Market Revenue and Forecast to 2028 (US$ Mn)
  • Figure 33. Mexico: Flowable Hemostats Market Revenue and Forecast to 2028 (US$ Mn)
  • Figure 34. Growth Strategies in the Flowable Hemostats Market (%)